table
5-HT RECEPTOR SUBTYPES
A summary of drug potencies at each of the five known S-HT
binding site subtypes is provided in Table 2. These data are discussed in
greater detail in the following section.
Table 1 Characteristics of 5-HT, S-HT», 5-HT,c, 5-HTp, and 5-HT, binding sites
S-HT
5-HTc
S-HTp
5-HT,
5-HTA
H-S-HT
H-S-HT
H-S-HI
H-Spiperone
H-S-HT
Radiolabeled
1231.CYI
H-Mesulergine
H-Mesulergine
H-8-OH¬
DPAT
Linans
1231-LSD
1231.LSD
H-Ipsapirone
(rat and
H-Ketanserin
H-WB 4101
mouse only)
Mianserin
H-Buspirone
H-N-methylspiperone
'H-PAPP
1231. Methyl-LSD
H-DOB
Layer IV
Raphe nuclei Substantia
Choroid
Basal
High
plexus
nigra
ganglia cortex
density
Hippocampus Globus
pallidus
Table 2 Drug affinities for 5-HTA, S-HTI», 5-HTIC, S-HTD, and 5-HT, receptors
Drug
potencies
S-HT
S-HT
5-HTp
5-HT,
S-HT
(K., nM)
5.CT
10
RU 24969
Mesulergine
Spiperone
5.CI
5-CT
5-HT
Mesulergine
8-OH-DPAT
Metergoline
5S-HT
5-HT
Methysergide
Methysergide
Metergoline
RU 24969
Metergoline
Mianserin
d-LSD
d-LSD
Methysergide
Metergoline
Metergoline
Mianserin
10-1000
Methysergide
5-HT
Mianserin
Methysergide
RU 24969
8-OH-DPAT
d-LSD
Spiperone
5-CT
d-LSD
Mesulergine
d-LSD
RU 24969
RU 24969
Mesulergine
» 1000 Mianserin
Mianserin
Spiperone
5-HT
8-OH-DPAT
Spiperone
Spiperone
8-OH-DPAT
Mesulergine
8-OH-DPAT
Data given are derived from Peroutka & Snyder (1979), Peroutka (1986), Hoyer et al (1985b), Heuring
—
